BEAM
Price
$22.03
Change
+$0.57 (+2.66%)
Updated
Jul 10 closing price
Capitalization
2.16B
32 days until earnings call
CGEM
Price
$7.84
Change
+$0.04 (+0.51%)
Updated
Jul 10 closing price
Capitalization
460.31M
27 days until earnings call
Interact to see
Advertisement

BEAM vs CGEM

Header iconBEAM vs CGEM Comparison
Open Charts BEAM vs CGEMBanner chart's image
Beam Therapeutics
Price$22.03
Change+$0.57 (+2.66%)
Volume$3.31M
Capitalization2.16B
Cullinan Therapeutics
Price$7.84
Change+$0.04 (+0.51%)
Volume$297.31K
Capitalization460.31M
BEAM vs CGEM Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CGEM commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and CGEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BEAM: $22.03 vs. CGEM: $7.84)
Brand notoriety: BEAM and CGEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 162% vs. CGEM: 75%
Market capitalization -- BEAM: $2.16B vs. CGEM: $460.31M
BEAM [@Biotechnology] is valued at $2.16B. CGEM’s [@Biotechnology] market capitalization is $460.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCGEM’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CGEM’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEM is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while CGEM’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • CGEM’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CGEM.

Price Growth

BEAM (@Biotechnology) experienced а +10.09% price change this week, while CGEM (@Biotechnology) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CGEM is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.16B) has a higher market cap than CGEM($460M). BEAM YTD gains are higher at: -11.169 vs. CGEM (-35.632). CGEM has higher annual earnings (EBITDA): -208.62M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CGEM (304M). CGEM has less debt than BEAM: CGEM (1.84M) vs BEAM (158M). BEAM has higher revenues than CGEM: BEAM (63.6M) vs CGEM (0).
BEAMCGEMBEAM / CGEM
Capitalization2.16B460M469%
EBITDA-399.03M-208.62M191%
Gain YTD-11.169-35.63231%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B304M401%
Total Debt158M1.84M8,587%
TECHNICAL ANALYSIS
Technical Analysis
BEAMCGEM
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
Declines
ODDS (%)
Bearish Trend 18 days ago
85%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBLGX64.75N/A
N/A
ClearBridge Large Cap Growth A
SEQAX17.34N/A
N/A
NAA World Equity Income A
WIEFX16.08N/A
N/A
Boston Trust Walden International Eq
EMRSX18.77N/A
N/A
JPMorgan Emerging Mkts Rsrch Enh Eq R6
HWSZX75.11N/A
N/A
Hotchkis & Wiley Small Cap Value Z

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+0.51%
MDGL - CGEM
50%
Loosely correlated
+1.96%
IDYA - CGEM
49%
Loosely correlated
-0.74%
DNLI - CGEM
48%
Loosely correlated
+2.33%
EYPT - CGEM
48%
Loosely correlated
+0.91%
BEAM - CGEM
48%
Loosely correlated
+2.66%
More